MA43703A - Compositions et procédés permettant d'augmenter l'absorption de fer chez un mammifère - Google Patents

Compositions et procédés permettant d'augmenter l'absorption de fer chez un mammifère

Info

Publication number
MA43703A
MA43703A MA043703A MA43703A MA43703A MA 43703 A MA43703 A MA 43703A MA 043703 A MA043703 A MA 043703A MA 43703 A MA43703 A MA 43703A MA 43703 A MA43703 A MA 43703A
Authority
MA
Morocco
Prior art keywords
mammal
compositions
methods
iron absorption
increasing iron
Prior art date
Application number
MA043703A
Other languages
English (en)
Inventor
Radics Gabor
John Gilmer
Mark Ledwidge
Pat O'flynn
Jun Wang
Michael Whelehan
Original Assignee
Solvotrin Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvotrin Therapeutics Ltd filed Critical Solvotrin Therapeutics Ltd
Publication of MA43703A publication Critical patent/MA43703A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA043703A 2016-03-15 2017-03-15 Compositions et procédés permettant d'augmenter l'absorption de fer chez un mammifère MA43703A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16160539 2016-03-15

Publications (1)

Publication Number Publication Date
MA43703A true MA43703A (fr) 2018-11-28

Family

ID=55640537

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043703A MA43703A (fr) 2016-03-15 2017-03-15 Compositions et procédés permettant d'augmenter l'absorption de fer chez un mammifère

Country Status (32)

Country Link
US (1) US11224615B2 (fr)
EP (1) EP3429560B1 (fr)
JP (1) JP7193145B2 (fr)
KR (1) KR102403292B1 (fr)
CN (1) CN109069430B (fr)
AU (1) AU2017232266B2 (fr)
BR (1) BR112018068571A2 (fr)
CA (1) CA3017556C (fr)
CL (1) CL2018002632A1 (fr)
CO (1) CO2018010940A2 (fr)
CR (1) CR20180488A (fr)
CU (1) CU20180108A7 (fr)
EA (1) EA201892065A1 (fr)
EC (1) ECSP18077068A (fr)
ES (1) ES3008084T3 (fr)
GE (2) GEP20227445B (fr)
HR (1) HRP20250187T1 (fr)
HU (1) HUE070063T2 (fr)
IL (1) IL261735B (fr)
MA (1) MA43703A (fr)
MX (1) MX2018011227A (fr)
MY (1) MY196575A (fr)
NI (1) NI201800089A (fr)
NZ (1) NZ747227A (fr)
PE (1) PE20181955A1 (fr)
PH (1) PH12018501994A1 (fr)
PL (1) PL3429560T3 (fr)
SA (1) SA518400019B1 (fr)
SG (1) SG11201807985XA (fr)
UA (1) UA125211C2 (fr)
WO (1) WO2017158030A1 (fr)
ZA (1) ZA201806814B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114027507B (zh) * 2021-11-18 2023-02-28 中国农业大学 一种口服凝胶铁补充剂及其制备方法
WO2024145451A2 (fr) * 2022-12-29 2024-07-04 Memorial Sloan-Kettering Cancer Center Méthodes de restauration du potentiel régénératif d'alvéoles pulmonaires âgées et de compartiments de cellules souches adultes âgées

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US505986A (en) 1893-10-03 Pio marfori
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US4067994A (en) 1976-03-26 1978-01-10 Zinpro Corporation Iron methionine complex salts
US4216144A (en) * 1977-10-20 1980-08-05 Ashmead H H Soluble iron proteinates
IT1150213B (it) 1982-03-02 1986-12-10 Italfarmaco Spa Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche
IT1186787B (it) 1985-11-06 1987-12-16 Mediolanum Farmaceutici Srl Ferro-derivati della globina e dell'acetilglobina dotati di elevata biodisponibilita',processo di preparazione e composizioni farmaceutiche
US5418010A (en) 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
JP3404294B2 (ja) * 1998-08-11 2003-05-06 雪印乳業株式会社 鉄−ホエー蛋白質加水分解物複合体
US6521247B1 (en) 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
SI1677613T1 (sl) * 2003-10-30 2012-11-30 Arla Foods Amba Stabilizatorji uporabni pri izdelavi namazov z nizko vsebnostjo maščob
CN1557481A (zh) * 2004-02-04 2004-12-29 高春平 防治缺铁性贫血的天然营养剂
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia
EP2056797A2 (fr) * 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH Système de libération contrôlée et procédé de préparation correspondant
CN101143011B (zh) 2007-10-09 2011-06-22 浙江大学 提高食物中铁素生物有效性的方法
US20090124572A1 (en) 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
CN101928742B (zh) 2009-06-23 2013-02-27 光明乳业股份有限公司 一种具有抗氧化性活性的乳清蛋白活性肽及其制备方法
US20120288531A1 (en) 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
BR112014000416A2 (pt) 2011-07-15 2017-01-10 Nestec Sa encapsulado de grau alimentício e processo para a produção do mesmo
AU2012311964B2 (en) * 2011-09-22 2016-09-22 Amip Buffered upper GI absorption promoter
WO2014148886A1 (fr) * 2013-03-22 2014-09-25 N.V. Nutricia Nutrition fermentée riche en lactose ayant une biodisponibilité de fer accrue
EP2995205A1 (fr) 2014-09-15 2016-03-16 Anabio Technologies Limited Compositions et procédés pour l'entretien de l'apport adéquat en fer chez un mammifère
GB201416293D0 (en) * 2014-09-15 2014-10-29 Solvotrin Therapeutics Ltd Methods and preparations

Also Published As

Publication number Publication date
CA3017556A1 (fr) 2017-09-21
HRP20250187T1 (hr) 2025-04-25
HUE070063T2 (hu) 2025-05-28
PE20181955A1 (es) 2018-12-17
UA125211C2 (uk) 2022-02-02
CO2018010940A2 (es) 2018-11-22
KR102403292B1 (ko) 2022-05-27
MX2018011227A (es) 2019-05-16
CA3017556C (fr) 2023-12-05
CR20180488A (es) 2019-03-12
CU20180108A7 (es) 2019-09-04
ZA201806814B (en) 2021-03-31
GEAP202214903A (en) 2022-06-27
AU2017232266B2 (en) 2022-10-06
ES3008084T3 (en) 2025-03-21
EP3429560C0 (fr) 2024-12-25
IL261735B (en) 2022-07-01
JP7193145B2 (ja) 2022-12-20
WO2017158030A1 (fr) 2017-09-21
NI201800089A (es) 2019-05-16
EP3429560A1 (fr) 2019-01-23
NZ747227A (en) 2022-11-25
KR20190006946A (ko) 2019-01-21
CN109069430B (zh) 2022-09-23
SG11201807985XA (en) 2018-10-30
EP3429560B1 (fr) 2024-12-25
PL3429560T3 (pl) 2025-04-28
ECSP18077068A (es) 2018-12-31
US20190054115A1 (en) 2019-02-21
JP2019511572A (ja) 2019-04-25
US11224615B2 (en) 2022-01-18
EA201892065A1 (ru) 2019-04-30
PH12018501994A1 (en) 2019-06-17
SA518400019B1 (ar) 2022-12-11
AU2017232266A1 (en) 2018-11-08
CN109069430A (zh) 2018-12-21
IL261735A (en) 2018-10-31
GEP20227445B (en) 2022-12-12
CL2018002632A1 (es) 2019-03-15
MY196575A (en) 2023-04-19
BR112018068571A2 (pt) 2019-04-16

Similar Documents

Publication Publication Date Title
EP2820159A4 (fr) Procédés et compositions permettant de traiter la maladie de huntington
EP3496739A4 (fr) Compositions et procédés de traitement de l'hypertension pulmonaire
EP3273944A4 (fr) Compositions et procédés permettant d'administrer des agents de type biomacromolécule
EP3592370A4 (fr) Compositions et procédés pour favoriser une flore microbienne saine chez un mammifère
EP2971164A4 (fr) Procédés et compositions pour classification d'échantillons
EP2387412A4 (fr) Procédés permettant d'augmenter l'adiponectine
EP2678434A4 (fr) Animaux génétiquement modifiés et procédés pour produire ceux-ci
EP3013957A4 (fr) Compositions et procédés de traitement d'échantillon
EP2761065A4 (fr) Compositions et procédés permettant d'effectuer des tests de toxigénicité
EP2862197A4 (fr) Appareil et procédés permettant d'inspecter des réticules en ultraviolet extrême
EP3708671C0 (fr) Procédés et compositions permettant la modification d'un locus cible
EP2925888A4 (fr) Compositions et procédés pour traiter le cancer
EP2627665A4 (fr) Procédés et compositions pour traiter l'hémophilie b
EP2809262A4 (fr) Dispositifs et procédés pour greffe d'anévrisme
EP2947990A4 (fr) Compositions et procédés pour traiter des organismes nuisibles
EP2943777A4 (fr) Procédés d'imagerie métabolique pour évaluer des ovocytes et embryons
PL3010506T3 (pl) Pridopidyna w leczeniu choroby huntingtona
EP2967052A4 (fr) Compositions et procédés pour moduler l'immunité chez les végétaux
EP2895865A4 (fr) Coffret de composition de détection du cancer de la vessie et procédés associés
EP2916916A4 (fr) Procédés pour modifier la couleur et l'aspect de cheveux
EP2381920A4 (fr) Procédés et compositions pour traiter p. acnes
EP2777068A4 (fr) Gabarit de damasquinage permettant l'assemblage et le transfert dirigés de nano-éléments
EP3394272A4 (fr) Compositions et procédés permettant de cibler efficacement des transgènes
EP2914619A4 (fr) Polypeptides érythroferrone et erfe, et procédés de régulation du métabolisme du fer
EP2839038A4 (fr) Compositions et procédés de détection d'espèces de candida